Impact of Sentinel Node Status and Other Risk Factors on the Clinical Outcome of Head and Neck Melanoma Patients; Stanley P. L. Leong, MD; Neil A. Accortt, PhD; Richard Essner, MD; Merrick Ross, MD; Jeffrey E. Gershenwald, MD; Barbara Pockaj, MD; Harald J. Hoekstra, MD; Carlos Garberoglio, MD; Richard L. White, Jr, MD; David Chu, MD; Merrill Biel, MD; Kim Charney, MD; Harold Wanebo, MD; Eli Avisar, MD; John Vetto, MD; Seng-Jaw Soong, PhD; for the Sentinel Lymph Node Working Group; Arch Otolaryngol Head Neck Surg. 2006;132:370-373.
Human Melanoma in Cyclosporine-Immunosuppressed Rats; Goodman, M.M.; McCullough, J.L.; Models in Dermatology, Maiback, H.; Lowe, N. (eds), Basel, Switzerland: Karger, S., Vol. 4, 249-252, 1989.
A Model of Human Melanoma in Cyclosporine-Immunosuppressed Rats; Goodman, M.M.; McCullough, J.L.; Biren, C.A.; Barr, R.J., Journal of Investigative Dermatology, 88(2): 141-144, 1987.